108 related articles for article (PubMed ID: 16365454)
1. Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion.
Barber DF; Bartolomé A; Hernandez C; Flores JM; Fernandez-Arias C; Rodríguez-Borlado L; Hirsch E; Wymann M; Balomenos D; Carrera AC
J Immunol; 2006 Jan; 176(1):589-93. PubMed ID: 16365454
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of PI3Kδ reduces kidney infiltration by macrophages and ameliorates systemic lupus in the mouse.
Suárez-Fueyo A; Rojas JM; Cariaga AE; García E; Steiner BH; Barber DF; Puri KD; Carrera AC
J Immunol; 2014 Jul; 193(2):544-54. PubMed ID: 24935930
[TBL] [Abstract][Full Text] [Related]
3. Enhanced phosphoinositide 3-kinase δ activity is a frequent event in systemic lupus erythematosus that confers resistance to activation-induced T cell death.
Suárez-Fueyo A; Barber DF; Martínez-Ara J; Zea-Mendoza AC; Carrera AC
J Immunol; 2011 Sep; 187(5):2376-85. PubMed ID: 21810603
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 3-kinase regulates the CD4/CD8 T cell differentiation ratio.
Rodríguez-Borlado L; Barber DF; Hernández C; Rodríguez-Marcos MA; Sánchez A; Hirsch E; Wymann M; Martínez-A C; Carrera AC
J Immunol; 2003 May; 170(9):4475-82. PubMed ID: 12707323
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic T cells in murine lupus exhibit spontaneous signaling activity through phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways.
Niculescu F; Nguyen P; Niculescu T; Rus H; Rus V; Via CS
Arthritis Rheum; 2003 Apr; 48(4):1071-9. PubMed ID: 12687551
[TBL] [Abstract][Full Text] [Related]
6. Optimal chemotactic responses of leukemic T cells to stromal cell-derived factor-1 requires the activation of both class IA and IB phosphoinositide 3-kinases.
Curnock AP; Sotsios Y; Wright KL; Ward SG
J Immunol; 2003 Apr; 170(8):4021-30. PubMed ID: 12682230
[TBL] [Abstract][Full Text] [Related]
7. PI3K/Akt signaling in peripheral T lymphocytes from systemic lupus erythematosus patients.
Beşliu AN; Pistol G; Marica CM; Bănică LM; Chiţonu C; Ionescu R; Tănăseanu C; Tamsulea I; Matache C; Stefănescu M
Roum Arch Microbiol Immunol; 2009; 68(2):69-79. PubMed ID: 20361524
[TBL] [Abstract][Full Text] [Related]
8. Differential PI3Kδ Signaling in CD4
Ahmad S; Abu-Eid R; Shrimali R; Webb M; Verma V; Doroodchi A; Berrong Z; Samara R; Rodriguez PC; Mkrtichyan M; Khleif SN
Cancer Res; 2017 Apr; 77(8):1892-1904. PubMed ID: 28108509
[TBL] [Abstract][Full Text] [Related]
9. The role of class I phosphoinositide 3-kinase in T-cell function and autoimmunity.
Fruman DA
Biochem Soc Trans; 2007 Apr; 35(Pt 2):177-80. PubMed ID: 17371231
[TBL] [Abstract][Full Text] [Related]
10. Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo.
Borlado LR; Redondo C; Alvarez B; Jimenez C; Criado LM; Flores J; Marcos MA; Martinez-A C; Balomenos D; Carrera AC
FASEB J; 2000 May; 14(7):895-903. PubMed ID: 10783143
[TBL] [Abstract][Full Text] [Related]
11. The p85alpha regulatory subunit of class IA phosphoinositide 3-kinase regulates beta-selection in thymocyte development.
Shiroki F; Matsuda S; Doi T; Fujiwara M; Mochizuki Y; Kadowaki T; Suzuki H; Koyasu S
J Immunol; 2007 Feb; 178(3):1349-56. PubMed ID: 17237381
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol-3-kinase-gamma is integral to homing functions of progenitor cells.
Chavakis E; Carmona G; Urbich C; Göttig S; Henschler R; Penninger JM; Zeiher AM; Chavakis T; Dimmeler S
Circ Res; 2008 Apr; 102(8):942-9. PubMed ID: 18323525
[TBL] [Abstract][Full Text] [Related]
13. Phosphoinositide-3 kinases critically regulate the recruitment and survival of eosinophils in vivo: importance for the resolution of allergic inflammation.
Pinho V; Souza DG; Barsante MM; Hamer FP; De Freitas MS; Rossi AG; Teixeira MM
J Leukoc Biol; 2005 May; 77(5):800-10. PubMed ID: 15860799
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation.
Ji H; Rintelen F; Waltzinger C; Bertschy Meier D; Bilancio A; Pearce W; Hirsch E; Wymann MP; Rückle T; Camps M; Vanhaesebroeck B; Okkenhaug K; Rommel C
Blood; 2007 Oct; 110(8):2940-7. PubMed ID: 17626838
[TBL] [Abstract][Full Text] [Related]
15. Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ.
Uehara M; McGrath MM; Ohori S; Solhjou Z; Banouni N; Routray S; Evans C; DiNitto JP; Elkhal A; Turka LA; Strom TB; Tullius SG; Winkler DG; Azzi J; Abdi R
Nat Commun; 2017 Oct; 8(1):951. PubMed ID: 29038423
[TBL] [Abstract][Full Text] [Related]
16. Role of phosphoinositide 3-kinase IA (PI3K-IA) activation in cardioprotection induced by ouabain preconditioning.
Duan Q; Madan ND; Wu J; Kalisz J; Doshi KY; Haldar SM; Liu L; Pierre SV
J Mol Cell Cardiol; 2015 Mar; 80():114-25. PubMed ID: 25575882
[TBL] [Abstract][Full Text] [Related]
17. Effects of 1,25(OH)
Ding Y; Liao W; He XJ; Xiang W
J Cell Mol Med; 2017 May; 21(5):975-985. PubMed ID: 28063200
[TBL] [Abstract][Full Text] [Related]
18. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
[TBL] [Abstract][Full Text] [Related]
19. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus.
Barber DF; Bartolomé A; Hernandez C; Flores JM; Redondo C; Fernandez-Arias C; Camps M; Rückle T; Schwarz MK; Rodríguez S; Martinez-A C; Balomenos D; Rommel C; Carrera AC
Nat Med; 2005 Sep; 11(9):933-5. PubMed ID: 16127435
[TBL] [Abstract][Full Text] [Related]
20. G1 arrest and high expression of cyclin kinase and apoptosis inhibitors in accumulated activated/memory phenotype CD4+ cells of older lupus mice.
Sabzevari H; Propp S; Kono DH; Theofilopoulos AN
Eur J Immunol; 1997 Aug; 27(8):1901-10. PubMed ID: 9295025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
